AGP Executive Report
Last update: 18 hours agoCancer Care Watch: ASCO 2026 highlights new GU oncology momentum: perioperative apalutamide plus ADT in high-risk localized prostate cancer is set for an ASCO plenary (PROTEUS), while bladder cancer data show intravesical rBCG added to chemo-immunotherapy hitting a 68% pCR in muscle-invasive disease (SAKK 06/19) and updated EV+P results keep delivering overall survival gains in metastatic urothelial cancer (EV-302/KEYNOTE-A39). Precision Oncology: A biomarker analysis from ENZAMET suggests the Decipher score could help refine when to use docetaxel in metastatic hormone-sensitive prostate cancer (mHSPC). Public Health & Policy: The U.S. HHS announced a Lyme and tick-borne illness push, including a CDC-led pilot to reduce tick populations and a goal to cut Lyme cases by 25% by 2035. Health System Risks: A major wave of healthcare cyberattacks exposed sensitive patient data, including Social Security numbers and medical records, affecting multiple U.S. providers. Global Outbreaks: Doctors Without Borders says the Ebola outbreak in eastern DRC is spreading faster than the response can keep up, with testing and supplies lagging. Care Delivery & Safety: A hospital in Bangladesh was found operating a bakery inside the facility, raising hygiene and newborn-death probe concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
